Current Ratio of Fulcrum Therapeutics, Inc. from 31 Mar 2020 to 31 Dec 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Fulcrum Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2020 to 31 Dec 2025.
Fulcrum Therapeutics, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 2431%, a 17% increase year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Change (%)

Fulcrum Therapeutics, Inc. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q4 2025	2431%	+356%	+17%	31 Dec 2025
Q3 2025	2283%	+329%	+17%	30 Sep 2025
Q2 2025	2273%	+312%	+16%	30 Jun 2025
Q1 2025	2223%	+334%	+18%	31 Mar 2025
Q4 2024	2075%	+161%	+8.4%	31 Dec 2024
Q3 2024	1954%	+195%	+11%	30 Sep 2024
Q2 2024	1961%	+277%	+16%	30 Jun 2024
Q1 2024	1888%	+546%	+41%	31 Mar 2024
Q4 2023	1914%	+787%	+70%	31 Dec 2023
Q3 2023	1759%	+645%	+58%	30 Sep 2023
Q2 2023	1684%	+628%	+60%	30 Jun 2023
Q1 2023	1343%	+349%	+35%	31 Mar 2023
Q4 2022	1127%	+247%	+28%	31 Dec 2022
Q3 2022	1114%	+421%	+61%	30 Sep 2022
Q2 2022	1055%	+519%	+97%	30 Jun 2022
Q1 2022	994%	+399%	+67%	31 Mar 2022
Q4 2021	880%	+301%	+52%	31 Dec 2021
Q3 2021	693%	+17%	+2.5%	30 Sep 2021
Q2 2021	536%	-333%	-38%	30 Jun 2021
Q1 2021	594%	-232%	-28%	31 Mar 2021
Q4 2020	579%			31 Dec 2020
Q3 2020	676%			30 Sep 2020
Q2 2020	869%			30 Jun 2020
Q1 2020	827%			31 Mar 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.